But the process may take months, pending Congressional approval.
Personal injury lawsuit ads targeting social media have become daily sightings. But are they doing more harm than good?
But is the U.S. ready to embrace it?
NIAID's Carl Dieffenbach, Ph.D., joins Anne Rancourt to discuss some key takeaways from the 10th International AIDS Society Conference on HIV Science.
Our new "Eyes on the End" series kicks off with an up-close-and-personal glimpse at what's driving the HIV epidemic in the Atlanta metropolitan area.
"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."
Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.
But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.
In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.
"At this year's International AIDS Conference ... we witnessed several pivotal developments in the global HIV response," Sean Hosein writes. "We also saw some setbacks in our efforts to prevent infections and improve the lives of people living with H...